Skip to main content
SpringerLink
Log in

Adjuvant and Neoadjuvant Treatment: Standard Treatment and Clinical Trials in the East

  • Chapter
  • First Online:
Gastric Cancer

  • 2578 Accesses

Abstract

Standard care of adjuvant treatment for potentially curable gastric cancer in Asia is to provide postoperative adjuvant chemotherapy after D2 surgery. To improve survival results of mainly for stage III patients, there are several clinical trials to test efficacy of new treatments, including new regimens as postoperative adjuvant, neoadjuvant chemotherapy, and postoperative or preoperative chemoradiotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Wu CW, Hsiung CA, Lo SS, Hsieh MC, Chen JH, Li AFY, et al. Nodal dissection for patients with gastric cancer: a randomized controlled trial. Lancel Oncol. 2006;7:309–15.

    Article  CAS  Google Scholar 

  2. Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ. Surgical treatment of gastric cancer: 15-year follow-up results of the randomized nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11:439–49.

    Article  PubMed  Google Scholar 

  3. Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345:725–30.

    Article  CAS  PubMed  Google Scholar 

  4. Sasako M. Gastric cancer—Eastern experience. Surg Oncol Clin N Am. 2012;21:71–7.

    Article  PubMed  Google Scholar 

  5. Sasako M, Saka M, Fukagawa T, Katai H, Sano T. Surgical treatment of advanced gastric cancer: Japanese perspective. Dig Surg. 2007;24:101–7.

    Article  CAS  PubMed  Google Scholar 

  6. Sasako M. Principles of surgical treatment for curable gastric cancer. J Clin Oncol. 2003;21(23s):274–5.

    Article  Google Scholar 

  7. Bang YJ, Kim YW, Yang HK, Chung HC, Park YK, Lee KH, et al. for the CLASSIC trial investigators. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label randomized controlled trial. Lancet. 2012;379:315–21.

    Article  CAS  PubMed  Google Scholar 

  8. Sasako M, Sakuramoto S, Katai H, et al. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol. 2011;29:4387–93.

    Article  CAS  PubMed  Google Scholar 

  9. Cunningham D, Allum WH, Stenning SP, Thompson JN, van de Velde CJH, Nicolson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11–20.

    Article  CAS  PubMed  Google Scholar 

  10. Sano T, Sasako M, Kinoshita T, Maruyama K. Recurrence of early gastric cancer. Cancer. 1993;72:3174–8.

    Article  CAS  PubMed  Google Scholar 

  11. Nashimoto A, Akazawa K, Isobe Y, Miyashiro I, Katai H, Kodera Y, et al. Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry. Gastric Cancer. 2013;16:1–27.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Jeong O, Park YK. Clinicopathological features and surgical treatment of gastric cancer in South Korea: the results of 2009 nationwide survey on surgically treated gastric cancer patients. J Gastric Cancer. 2011;11:69–77.

    Article  PubMed Central  PubMed  Google Scholar 

  13. Japan Gastric Cancer Association. Japanese classification of gastric carcinoma. 2nd English ed. Gastric Cancer. 1998;1:10–24.

    Article  Google Scholar 

  14. International Union Against Cancer (UICC). TNM classification of malignant tumours. 7th ed. Singapore: Wiley-Blackwell; 2009.

    Google Scholar 

  15. Noh SH, Park SR, Yang HK, Chung HC, Kim SW, Kim HH, Choi JH, Kim HK, Yu W, Lee JI, Shin DB, Ji J, Chen JS, Lim Y, Ha S, Bang YJ, on be half of the CLAASIC trial investigators. Adjuvant capecitabibe plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial. Lanect Oncol 2014;15:1389–96.

    Google Scholar 

  16. Smalley SR, Benditte JK, Haller DG, Hundahl SA, Estes NC, Ajani JA, et al. Update analysis of SWOG-directed intergroup study 0116: a phase III trial of adjuvant radiochemotherapy versus observation after curative gastric cancer resection. J Clin Oncol. 2012;30:2327–33.

    Article  CAS  PubMed  Google Scholar 

  17. Lee J, Lim DH, Kim S, Park SK, Park JO, Park YS, et al. Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent Capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial. J Clin Oncol. 2012;30:268–73.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Upper Gastrointestinal Surgery, Hyogo College of Medicine, 1-1, Mukogawa-cho, Hyogo, Nishinomiya, 663-8501, Japan

    Mitsuru Sasako MD, PhD

Authors
  1. Mitsuru Sasako MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mitsuru Sasako MD, PhD .

Editor information

Editors and Affiliations

  1. Gastric and Mixed Tumor Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA

    Vivian E. Strong

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Sasako, M. (2015). Adjuvant and Neoadjuvant Treatment: Standard Treatment and Clinical Trials in the East. In: Strong, V. (eds) Gastric Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-15826-6_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-15826-6_22

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-15825-9

  • Online ISBN: 978-3-319-15826-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation